mbxbio.com (MBX): Volume dana dhuwit perusahaan

Simbol resmi perusahaan mbxbio.com (MBX)

MBX Biosciences Inc (MBX) faces uncertainty regarding early-stage testing of hypoparathyroidism drugs and a capital deficit. The company's cash reserve on the GURU.Markets service base chart illustrates liquidity dynamics, where the 0.48 mark records this metric. While MBX Biosciences Inc (MBX) seeks to accelerate peptide clinical trials, the lack of revenue and high expenditures create significant vulnerabilities against market behemoths.

MBX Corp - Dhuwit awis lan setara dhuwit awis perusahaan MBX (periode 14.09.2024 - 21.11.2026)

Rincian analitis perusahaan MBX Biosciences (MBX)

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:MBX MBX Biosciences, Inc.
Produk merek mbxbio.com

For MBX Biosciences Inc, which is developing endocrine drugs, this indicator determines the current liquidity reserve available to support R&D processes. The metric tracks the daily cash balance, allowing for the monitoring of the actual burn rate across short cycles. Analysis of this cash volume chart reveals the funding dynamics for purchasing analytical equipment and paying for contract manufacturing. The stability of this indicator confirms the company's ability to maintain development pace without the urgent need to raise debt capital.

Pesaing MBX Biosciences Inc (MBX)

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)